Company / R&D per Share
Arcellx, Inc. R&D per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.90
FY2025
5-year range
$2.90 / $105.03
FY2021-FY2025
Trend
-3.4%
vs FY2024
Sector context
#75 of 208
Health Care
What the data says
At $2.90, Arcellx, Inc.'s r&d per share ranks #75 of 208 in the Health Care sector. R&D per Share has declined for 4 consecutive years, from $105.03 in FY2021 to $2.90 in FY2025.
Based on SEC 10-K filings.
2.90 in FY2025 with a 3-year CAGR of -11.0%.
Declined from $3.03 to $2.90 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -11.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#75 of 208 in Health CareTop 36% of 208This company $2.90 Sector average $28.82
▼
-89.9% below sector average
Key checks
Key Insights
- Arcellx, Inc.'s r&d per share has declined for 4 consecutive years.
- In FY2025, r&d per share decreased 3.4% year-over-year.
- Ranks #75 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.02 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.90 | -3.4% |
| FY2024 | $3.00 | -1.0% |
| FY2023 | $3.03 | -26.2% |
| FY2022 | $4.11 | -96.1% |
| FY2021 | $105.03 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026